Here are eight highlights:
1. Smith & Nephew saw revenue of about $1.19 billion in the second quarter of 2017.
2. In the second quarter, the company saw a 13 percent jump in emerging market revenue.
3. Smith & Nephew recorded strong growth in knee implants ($246 million) and advanced wound devices ($49 million) for the second quarter of 2017.
4. The sports medicine, trauma and other segment saw revenue of $480 million in the second quarter of 2017.
5. The company’s first half of 2017 revenue was about $2.33 billion.
6. The first half of 2017’s operating profit was $414 million, with an operating profit margin of 17.7 percent.
7. The company’s trading profit for the first half of 2017 was $493 million, with a trading profit margin of 21.1 percent.
8. Smith & Nephew had $438 million in cash generated from operating activities.
More articles on devices:
Integra LifeSciences saw $282.2M Q2 revenue — 6 observations
FDA clears CTL’s MATISSE Titanium ACIF Cage: 4 things to know
WishBone Medical reveals Exact Osteotomy System for pediatric orthopedic surgery cuts — 5 points
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
